The first DRM-free album from EMI was released on Monday and it was not a new album. The album chosen to herald in the new age of music downloads was Damon Albarn's The Good, the Bad and the Queen, originally released in January. Additionally, it is not even available as a DRM-free album on Apple Inc.'s (NASDAQ:AAPL) iTunes, instead the band's own website in association with 7digital.com is offering the 320 kbps tracks from the album. I blogged about how the band had performed a short set at the announcement on Monday before, but now it seems (or did seem) that the band would be the first to enter the DRM-free world fully (I had previously thought the band's endeavors were limited to the new single "Green Fields" - which I downloaded after the announcement).
I can't help but wonder if any change has been noticed with the announcement and the release of this album as the first DRM-free. Almost three months after it was initially released, I know that I already have it, and will not purchase a second copy (even if the quality is high). It seems that for the first truly "new" album released under the DRM-free agreement, we will have to wait until May when the entire system becomes operational.
On Sunday I had blogged that Apple's shares were down .84 points on last Friday, closing slightly above 92.9. Yesterday the stock rose another .41 points for the week, bringing the shares to 94.68, an almost 2 point jump. It's probably to early to say whether the DRM-free announcement has made any impact, but with shares rising over a week, some improvement should be connected.
Last updated: February 10, 2012: 11:20 AM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
TheFlyOnTheWall.com Headlines
- Synacor IPO opens for trading at $5.75
- Gartner to host investor day
- SEI Investments upgraded to Buy from Neutral at Garp Research
- Crane to host analyst meeting
- Synacor indicated to open $5.55
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Savings Experiment: Snow Removal
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?

